Platelet thromboxane inhibition by low‐dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation

Platelet thromboxane inhibition by low‐dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation

Abstract Low‐dose aspirin is currently recommended for patients with polycythemia vera (PV), a myeloproliferative neoplasm with increased risk of arterial and venous thromboses. Based on aspirin pharmacodynamics in essential thrombocythemia, a twice‐daily regimen is recommended for patients with PV...

Full description

Bibliographic Details
Main Authors: Giovanna Petrucci, Alberto Giaretta, Paola Ranalli, Viviana Cavalca, Alfredo Dragani, Benedetta Porro, Duaa Hatem, Aida Habib, Elena Tremoli, Carlo Patrono, Bianca Rocca
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Clinical and Translational Science
Online Access:https://doi.org/10.1111/cts.13415

Similar Items

Similar Items